SHANGHAI FUDAN FORWARD S&T CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.87 CNY | -1.78% |
|
-13.62% | -32.22% |
| 2023 | Shanghai Fudan Forward S&T Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 | CI |
| 2023 | Fudan Forward S&T to Auction Office Property For At Least 31 Million Yuan | MT |
| Sales 2021 | 1.04B 144M | Sales 2022 | 789M 109M | Capitalization | 3.89B 537M |
|---|---|---|---|---|---|
| Net income 2021 | -105M -14.51M | Net income 2022 | -3M -414K | EV / Sales 2021 | 4.74 x |
| Net Debt 2021 | 195M 26.96M | Net Debt 2022 | 207M 28.58M | EV / Sales 2022 | 5.19 x |
| P/E ratio 2021 |
-45
x | P/E ratio 2022 |
-1,078
x | Employees | 1,426 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 65.6% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.78% | ||
| 1 week | -13.62% | ||
| Current month | -16.05% | ||
| 1 month | -21.98% | ||
| 3 months | -26.98% | ||
| 6 months | -29.12% | ||
| Current year | -32.22% |
1 week
3.67
4.45
1 month
3.675.04
Current year
3.675.95
1 year
3.676.66
3 years
3.678.07
5 years
3.6714.22
10 years
3.6717.96
| Managers | Title | Age | Since |
|---|---|---|---|
Zhi Bin Yu
IRC | Investor Relations Contact | - | - |
Yue Zhuang
PRN | Corporate Officer/Principal | 40 | 20-12-07 |
Min Shen
SEC | Corporate Secretary | 46 | 00-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Wei Qian
BRD | Director/Board Member | 61 | 20-12-07 |
Yue Zhuang
PRN | Corporate Officer/Principal | 40 | 20-12-07 |
Yan Lu
BRD | Director/Board Member | 43 | 20-12-07 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +1.04% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 3.87 | -1.78% | 6,208,899 |
| 24-04-17 | 3.94 | +7.07% | 9,481,091 |
| 24-04-16 | 3.68 | -9.58% | 12,073,840 |
| 24-04-15 | 4.07 | -7.92% | 11,034,620 |
| 24-04-12 | 4.42 | -1.34% | 3,752,950 |
End-of-day quote Shanghai S.E., April 17, 2024
More quotes
SHANGHAI FUDAN FORWARD S&T CO., LTD is a China-based company, principally engaged in the manufacture and distribution of pharmaceuticals. The Company's pharmaceuticals include digestive system drugs, nervous system drugs, antineoplastic drugs, circulatory drugs, immune function medications and others. The Company is also engaged in the provision of financial insurance software products. It distributes its products within domestic markets and to overseas markets.
Sector
Pharmaceuticals
Calendar
2024-04-29
- Q4 2023 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -32.22% | 363M | |
| +19.58% | 43.54B | |
| +17.28% | 21.74B | |
| +7.56% | 13.02B | |
| +6.06% | 13.53B | |
| +33.98% | 11.28B | |
| -10.57% | 6.99B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +7.71% | 5.09B |
- Stock Market
- Equities
- 600624 Stock
